Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin-induced diabetic rats

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 6, 2010, Pages 448-454

  Liu, Jun ^a   He, Ting ^a   Lu, Qian ^a   Shang, Jing ^a   Sun, Hongbin ^a   Zhang, Luyong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Asiatic acid; Beta cell mass; Diabetic rats; Type 1 diabetes

Indexed keywords

ASIATIC ACID; CITRIC ACID; GLUCOSE; INSULIN; PROTEIN BCL XL; PROTEIN KINASE B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCAGON BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; INSULIN-SECRETING CELLS; MALE; PENTACYCLIC TRITERPENES; RATS; RATS, WISTAR;

EID: 77956647066     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1101     Document Type: Article

References (27)

1. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21: C11-C14.
2. Staeva-Vieira T, Peakman M, Von Herrath M. Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes. Clin Exp Immunol 2007; 148: 17-31. (Pubitemid 46364996)
3. Harrison LC, Honeyman MC, Steele CE, et al. Pancreatic β-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 2004; 27: 2348-2355.
4. Sutherland DE, Gruessner A, Hering BJ. Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Endocrinol Metab Clin North Am 2004; 33: 135-148. (Pubitemid 38438427)
5. Noguchi H. Stem cells for the treatment of diabetes. Endocr J 2007; 54: 7-16.
6. Lock LT, Tzanakakis ES. Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng 2007; 13: 1399-1412.
7. Ghofaili KA, Fung M, Ao Z, et al. Effect of exenatide on Bcell function after islet transplantation in type 1 diabetes. Transplantation 2007; 83: 24-28. (Pubitemid 46104966)
8. Mu J, Woods J, Zhou YP, et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic betacell mass and function in a rodent model of type 2 diabetes. Diabetes 2006; 55(3): 1695-1704.
9. Riche DM, East HE, Riche KD. Impact of sitagliptin on markers of beta-cell function: a meta-analysis. Am J Med Sci 2009; 337(3): 321-328.
10. (a) Zhang P, Hao J, Liu J, et al. Efficient synthesis of morolic acid and related triterpenes starting from betulin. Tetrahedron 2009; 65: 4304-4309;
11. (b) Cheng KG, Liu J, Liu XF, et al. Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase. Carbohy Res 2009; 344: 841-850;
12. (c) Zhang LY, Chen J, Gong YC, et al. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylase. Chem Biodiv 2009; 6: 864-874;
13. (d) Wen XA, Sun HB, Liu J, et al. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structureactivity relationships and X-ray crystallographic studies. J Med Chem 2008; 51: 3540-3554;
14. (e) Hao J, Zhang P, Wen XA, et al. Efficient access to 2-isobetulinic acid, 2-isooleanolic acid and 2-isoursolic acid. J Org Chem 2008; 73: 7405-7408;
15. (f) Cheng KG, Zhang P, Liu J, et al. Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase. J Nat Prod 2008; 71: 1877-1880;
16. (g) Wen XA, Xia J, Cheng KG, et al. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases. Bioorg Med Chem Lett 2007; 17(3): 5777-5782;
17. (h) Liu J, Sun HB, Duan WG, et al. Maslinic acid reduces blood glucose and body weight in KK-Ay mice. Biol Pharm Bull 2007; 30(3): 2075-2078;
18. (i) Liu J, Sun HB, Wang XF, et al. Effects of oleanolic acid and maslinic acid on hyperlipidemia. Drug Develop Res 2007; 68(3): 261-266;
19. (j) Wen XA, Zhang P, Liu J, et al. Pentacyclic triterpenes. Part 2: synthesis and biological activity of maslinic acid derivatives as inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett 2006; 16: 722-726;
20. (k) Chen J, Liu J, Zhang LY, et al. Pentacyclic triterpenes. Part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett 2006; 16: 2915-2919.
21. Soumyanath A, Zhong YP, Gold SA, et al. Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in vitro. J Pharm Pharmacol 2005; 57(3): 1221-1229.
22. Mutayabarwa CK, Sayi JG, Dande M. Hypoglycaemic activity of Centella asiatica (L) Urb. East Cent Afri J Pharm Sci 2003; 6(2): 30-35.
23. Garcia-Ocana A, Vasavada RC, Cebrian A, et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 2001; 50: 2752-2762.
24. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13: 96-107.
25. Rother KI. Diabetes treatment - bridging the divide. N Engl J Med 2007; 356: 1499-1501.
26. Shapiro AM, Ryan EA, Lakey JR. Diabetes. Islet cell transplantation. Lancet 2001; 358: (suppl.): S21.
27. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710-719.